483 Bi-Coastal Pharma International Sep 2020

483 Bi-Coastal Pharma International Sep 2020

Shirley Wen FDA$119.00 - Available Now

FDA investigators audited the Bi-Coastal Pharma International - Shrewsbury, NJ, United States facility and issued inspectional observations (via FDA 483) on 14 Sep 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Sep 2020
  • Location: Shrewsbury, United States
  • FEI: 3013263547
Add To Cart